Noguchi, Masafumi
Kohno, Susumu
Pellattiero, Anna http://orcid.org/0000-0002-9793-3493
Machida, Yukino
Shibata, Keitaro
Shintani, Norihito
Kohno, Takashi http://orcid.org/0000-0002-5371-706X
Gotoh, Noriko http://orcid.org/0000-0003-3733-260X
Takahashi, Chiaki http://orcid.org/0000-0003-3390-9563
Hirao, Atsushi
Scorrano, Luca http://orcid.org/0000-0002-8515-8928
Kasahara, Atsuko
Article History
Received: 7 January 2023
Revised: 18 March 2023
Accepted: 23 March 2023
First Online: 5 April 2023
Competing interests
: LS and AP are inventors of a patent (EP3996708A1) describing MYLS22 as an anticancer therapeutic. LS receives sponsored research agreements from Nanna Therapeutics Ltd and Healx Therapeutics Ltd on topics unrelated to the content of this article.